DGAP-News: Eckert & Ziegler: Shareholders approve dividend of 1.20 EUR. Frank Perschmann joins Supervisory Board


 

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Dividend/Personnel
Eckert & Ziegler: Shareholders approve dividend of 1.20 EUR. Frank Perschmann joins Supervisory Board

29.05.2019 / 16:00
The issuer is solely responsible for the content of this announcement.


 

Berlin, 29 May 2019. Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry is paying its shareholders a dividend increased by 50%, thus bringing it to 1.20 EUR (pevious year 0.80 EUR) for each dividend-bearing share in the financial year 2018. This was approved by the Annual General Meeting (AGM) on May 29, 2019 and allows the shareholders to participate also this year in the company's success in the form of an increased dividend.

During the AGM on May 29, 2019 Frank Perschmann was elected as new member to the Supervisory Board. Frank Perschmann is a graduate engineer and disposes of an extensive expertise in management and IT issues. He follows Prof. Dr. Detlev Ganten whose term ended with this year's AGM. The Supervisory Board and Executive Board thank Prof. Dr. Ganten for his long-term and strong commitment for the company.

About Eckert & Ziegler.
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with around 800 employees, is one of the world's largest providers of isotope-related components for radiation therapy and nuclear medicine.
Contributing to saving lives.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com



29.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 816515

 
End of News DGAP News Service

816515  29.05.2019 

fncls.ssp?fn=show_t_gif&application_id=816515&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2012 2013 2014 2015 2016 2017 2018 2019e
Umsatzerlöse1 120,00 117,14 127,26 139,75 137,94 138,63 168,71 180,00
EBITDA1,2 27,48 22,07 20,10 26,98 24,97 26,62 32,14 32,30
EBITDA-Marge3 22,90 18,84 15,79 19,31 18,10 19,20 19,05 17,94
EBIT1,4 19,73 12,82 12,96 18,22 16,23 17,97 23,39 23,50
EBIT-Marge5 16,44 10,94 10,18 13,04 11,77 12,96 13,86 13,06
Jahresüberschuss1 10,29 9,09 6,50 10,37 9,79 15,12 16,89 19,00
Netto-Marge6 8,58 7,76 5,11 7,42 7,10 10,91 10,01 10,56
Cashflow1,7 16,57 14,65 10,65 16,23 19,83 26,83 21,21 22,50
Ergebnis je Aktie8 1,95 1,72 1,28 2.03 1,81 2,78 3,12 4,10
Dividende8 0,60 0,60 0,60 0,60 0,66 0,80 1,20 1,40
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2018 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Eckert & Ziegler
WKN Kurs in € Einschätzung Börsenwert in Mio. €
565970 179,400 Halten 949,56
KGV 2020e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
42,71 17,04 2,590 89,50
KBV KCV KUV EV/EBITDA
7,31 44,77 5,63 28,278
Dividende '19 in € Dividende '20e in € Div.-Rendite '19e
in %
Hauptversammlung
1,40 1,40 0,78 17.06.2020
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
12.05.2020 13.08.2020 12.11.2019 31.03.2020
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
6,43% 42,63% 190,76% 173,06%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Eckert & Ziegler Strahlen- und Medizintechnik AG  ISIN: DE0005659700 können Sie bei DGAP abrufen

Medtech , 565970 , EUZ , XETR:EUZ